XML 73 R60.htm IDEA: XBRL DOCUMENT v3.10.0.1
Derivative Financial Instruments (Schedule of Effects and Locations of Gains or Losses Recognized in Income) (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2018
Oct. 01, 2017
Sep. 30, 2018
Oct. 01, 2017
Derivative Instruments, Gain (Loss) [Line Items]        
Net revenue $ 400,586 $ 355,483 $ 1,112,379 $ 1,009,863
Cost of revenue 276,394 252,388 774,510 717,900
Research and development 35,253 23,127 95,571 69,167
Sales and marketing 49,005 40,311 139,646 115,001
General and administrative 23,268 14,229 60,354 40,373
Amount Reclassified from AOCI | Foreign currency forward contracts | Designated as Hedging Instrument | Cash Flow Hedges        
Derivative Instruments, Gain (Loss) [Line Items]        
Net revenue [1] 1,031 (4,401) 246 (3,374)
Cost of revenue [1] (7) 19 (8) 5
Research and development [1] 2 84 88 10
Sales and marketing [1] (138) 629 (65) 380
General and administrative [1] $ (41) $ 109 $ (50) $ 67
[1] Refer to Note 11, Stockholders' Equity, which summarizes the accumulated other comprehensive income activity related to derivatives.